Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT04026412

A Phase 3, Randomized, Open Label Study to Compare Nivolumab plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Durvalumab in Previously Untreated, Locally Advanced Non-small Cell Lung Cancer (LA NSCLC)

Status

Open

Conditions

Other

Phases

III

Age Group

Adult

Main Investiagtor

Vu, John

Practice

Lung

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT04026412

Secondary Trial ID Number

CA209-73L

Keywords

Treatment